Contravisory Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

Contravisory Investment Management’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,454	Closed	-$265K	–	371
2023 Q2	$265K	Hold	4,454	–	–	0.07%	178
2023 Q1	$279K	Buy	4,454 +347	+8%	+$21.7K	0.08%	166
2022 Q4	$257K	Buy	4,107 +572	+16%	+$32.8K	0.07%	172
2022 Q3	$176K	Hold	3,535	–	–	0.06%	188
2022 Q2	$208K	Buy	3,535 +1,090	+45%	+$60.1K	0.07%	179
2022 Q1	$129K	Buy	+2,445	New	+$141K	0.04%	209
2020 Q3	–	Sell	-3,816	Closed	-$156K	–	274
2020 Q2	$156K	Buy	+3,816	New	+$153K	0.06%	167

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Contravisory Investment Management's PBH Position: Q3 2023 in Review

Contravisory Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q3 2023, closing a stake of 4,454 shares — an estimated $265K sold.

Contravisory Investment Management first reported a position in PBH in Q2 2020 and held it in 7 quarters. The position peaked at $279K in Q1 2023. 279 funds tracked by Wall St. Rank hold PBH as of Q3 2023.

Contravisory Investment Management reported no remaining Prestige Consumer Healthcare position as of Q3 2023 after selling out during the quarter.
Contravisory Investment Management sold 4,454 Prestige Consumer Healthcare shares in Q3 2023, an estimated $265K.
Contravisory Investment Management first reported a position in Prestige Consumer Healthcare in Q2 2020 and held it in 7 quarters.
Contravisory Investment Management's Prestige Consumer Healthcare position peaked at $279K in Q1 2023.
279 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2023.

Based on Contravisory Investment Management's 13F filing for Q3 2023, filed 10 Oct 2023.